This article is more than 5 years old. Information may no longer be current.

VIDEO: OSD management crucial to surgical outcomes

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Good long-term outcomes are difficult to achieve in refractive and cataract surgery patients if ocular surface disease is not effectively managed, according to David Hardten, MD, here at the Twin Cities Ocular Surface Disease Symposium.

“It’s important to identify the fact that they have ocular surface disease and educate them about it and figure out a treatment plan that will be useful for them preoperatively and postoperatively,” he said.

Disclosure: Hardten reported he has lectured for, consulted for or received speaking honoraria from: Allergan, Johnson & Johnson, Shire and TearFilm.